Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

AGE

AgeX Therapeutics (AGE)

AgeX Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:AGE
일자시간출처헤드라인심볼기업
2024/03/2306:27GlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
2024/03/0806:49Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
2024/03/0806:47Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2024/03/0721:47Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
2024/02/1506:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
2024/02/1414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
2024/02/0706:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2024/02/0521:19Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
2024/01/2006:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2024/01/1907:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
2024/01/1806:19Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
2024/01/1623:11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
2024/01/1206:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2024/01/1006:16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
2024/01/0606:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2023/12/2906:02Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2023/12/1906:25Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2023/12/1407:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
2023/12/0906:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2023/12/0206:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2023/11/1806:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2023/11/1706:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
2023/11/1523:38Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
2023/11/1506:25Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2023/11/1506:05Business WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
2023/11/0806:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
2023/11/0806:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
2023/11/0706:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
2023/11/0205:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
2023/10/0705:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
 검색 관련기사 보기:AMEX:AGE